The use of integrated/closed intravenous catheters is rapidly increasing over conventional intravenous (IV) catheters due to the capacity of integrated catheters to apply power while injecting medicine into the circulation. Integrated/Closed catheters are used for injecting contrast media into the circulation system before computed tomography (CT) imaging. Many self-catheterization kits come with an inducer tip that aids in bypassing the greatest amount of bacteria concentrated in the first few millimeters of the urethra.
The integrated peripheral intravenous catheter also reduces the risk of contamination and infection as well as accidental disconnection owing to being equipped with some advanced special features that truly set this catheter type apart. For instance, these catheters are sometimes called “touchless” or “no-touch” catheters because fingers will never have to directly touch the catheter tube.
Most integrated/closed system catheters are perfect for travel or carrying. It’s also convenient for most people because it comes ready to use. Some closed system catheters also offer gripping aids or easy-to-open packaging for those who have limited hand dexterity, such as people with spinal cord injuries or severe arthritis.
Closed PIVC integrates advanced catheter stabilization to help cost-effectively comply with nursing guidelines while maximizing patient outcomes. NovaCath is the first and only peripheral IV catheter designed to reduce catheter movements in all directions with an advanced stabilization frame that absorbs forces away from the insertion site integrating closed extension set technology.
By integrating closed extension set technology, this catheter also helps in simplify and standardize the IV catheter setup process, while reducing the risk of exposure to bloodborne pathogens. As a result, maximizing catheter stabilization may help your efforts to minimize catheter movement and associated complications.
Moreover, Closed PIVCs management could be a ground-breaking approach that adds knowledge updates to the scope of professional nursing practice for nurses involved in peripheral cannula patients. In common this scope needs to be investigated as it will help the practitioner nurse to conversant with relevant research underpinning the practical aspects of the nursing procedure involved in the catheter.
Chronic disease is the leading cause of death and disability and the leading driver of the United States' $3.5 Trillion in Annual Health Care Costs. As per the National Center for Chronic Disease Prevention and Health, 6 in 10 adults in the US have a chronic disease at some point in their lives. Increasing utilization of peripheral intravenous catheters in the treatment of these chronic diseases, leading to hospitalization is anticipated to drive the market over the forecast period.
People suffering from cardiovascular diseases or those who are at high cardiovascular risk also need early detection and management. As per the American Heart Association Research Report 2018, Cardiovascular disease is listed as the underlying cause of death, accounting for nearly 836,546 deaths in the United States. This is nearly 1 out of every 3 deaths in the country and about 2,300 Americans die of cardiovascular disease each day, which is an average of 1 death every 38 seconds. Therefore, the increasing burden of cardiovascular diseases, including coronary artery diseases, is anticipated to boost the usage of peripheral catheters and drive the market over the forecast period.
With every passing day, a higher number of hospitals are shifting towards minimally invasive procedures. This concept has been equally appreciated by the patient and provider both, benefits to the patient being early discharge and return to normalcy and for the provider a faster turnaround thus higher profitability. This phenomenon has been helped by advancements in the field of catheterization.
Rising awareness about the minimally invasive surgeries coupled with rising usage of advanced materials such as Teflon and polytetrafluoroethylene in products has also boosted its demand. Advancements in the field of coronary stents have helped the interventional procedures to grow 10 times in the last few years. This phenomenon is going to get an impetus courtesy of the recent developments in the field of coronary stents i.e. absorbable stents. Furthermore, with time becoming a precious commodity a significant chunk of the population is opting for catheters which can provide ease in treatment procedures, also within the home environment. This phenomenon helps the patients in saving time and utilizes the saved time for other productive activities.
Moreover, this transition has led to greater interest from the foreign sector and is likely to see further activity from the government sector. These factors are driving the growth of the market in the forecast period.
The North American peripheral catheters market is expected to expand at a sluggish CAGR of 7% during the forecast period (2022-2029). In the North American region, the United States holds the dominant share of about 43% in 2020, followed by Canada. The United States is the most lucrative market for peripheral catheters. The growth in the region is due to the well-established healthcare infrastructure, favorable government initiatives, and numerous private and government hospitals which are providing a facility for catheterization. The North American peripheral catheters market is a fairly consolidated market with the market being dominated by the top 5 companies.
The North American peripheral catheter market is growing due to several factors such as the growing geriatric population, rising prevalence of chronic diseases, and growing healthcare expenditure. Also, the growing technological advancements in peripheral I.V. catheters are further propelling the growth of the market. The peripheral IV catheters have a major benefit of administering medicine directly into the flow of blood which is the reason it is commonly used for patients undergoing surgeries, emergency patients, pediatric patients, geriatric patients, and patients who are unable to swallow food. Such factors shall boost the peripheral intravenous catheters market growth.
Based on design type, the multiple lumen market is estimated to grow at a CAGR of 8.14% during the forecast period (2022-2029). The multiple lumen catheters are part of a complete line of critical care catheters offered with no natural rubber latex components to reduce the risk of patient latex allergy or hypersensitivity, without compromising performance. In many medical procedures, more than one activity takes place through the same device. Multi-lumen catheter tubes allow for flushing and aspiration, heating and cooling, the flow of liquid and the passage of air, and the infusion of drugs while monitoring flow rates.